Hello,
Pleased to share another publication from this August. Please take a look at the summary and key points below. Circulating for your awareness, it will also be added to the marketing website.
Assessing sociodemographic and regional disparities in Oncotype DX Genomic Prostate Score uptake
Cancer
https://doi.org/10.1002/cncr.35511
This real-world evidence study was designed to identify sociodemographic and regional factors associated with GPS uptake. The study analyzed data from 111,434 men diagnosed with very low-, low-, and intermediate-risk prostate cancer registered in the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) population-based cancer program between 2013 and 2017. The average age was 63.8 + 7 years; 70.5% were White, 15.2% were African-American, and 9% were Asian-American. Of 111,434 men, 6,014 received the GPS test. African Americans were 30% less likely to receive the GPS than White Americans. Men in the highest socioeconomic status were 62% more likely to receive the GPS than those in the lowest socioeconomic status. Ultimately, the GPS uptake was statistically significantly higher among men residing in the Northeast, West, and Midwest compared to the South.
Key Points:
- This is a large population study of men with very low-, low-, and favorable intermediate-risk prostate cancer
- The study identified racial, ethnic, socioeconomic, and regional differences in GPS uptake
- Almost all racial and ethnic minoritized groups had lower odds of GPS uptake compared to White men
- GPS uptake increased with increasing socioeconomic status and was 62% higher for men residing in the highest vs. lowest neighborhoods